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ation sites on synthase. They have designated the sites as la,
lb, 2, 3a, 3b, 3c, and 5. They have further shown that site 2
is Ser-7 (5). As phosphate is added to the various sites, less
active forms of synthase are produced with different kinetic
parameters for the allosteric activator glucose-6-P and the
substrate UDPglucose (6).
It is generally accepted that several well characterized kinases can phosphorylate and inactivate glycogen synthase.
These include skeletal muscle CAMP-dependent protein kinase (7, 8) which is regulated by intracellular levels of CAMP
and skeletal muscle phosphorylase kinase (9-12) which is
regulated by eaz+ andcalmodulin (13,14). Payne and Soderling (15) and Ahmad et al. (16) have shown that liver contains
a CaZ+-calmodulin-dependentkinase thatis distinct from
phosphorylase kinase, and Woodgett et al. (17) have isolated
a similar kinase from skeletal muscle. Recently, it hasbecome
clear that a phosvitin/casein kinase is capable of catalyzing
phosphorylation but not inactivation of glycogen synthase.
This kinase has been designated PCo.7by DePaoli-Roach et
al. (15, 19), casein kinase 2 by Huang et al. (20), and GSK-5
by Cohen et al. (21). In addition, glycogen synthase is phosphorylated by other cyclic nucleotide-independent and Cazccalmodulin-independent glycogen synthase kinases whose
regulatory mechanisms have not yet been elucidated (18, 21,
22).
Most of the work with glycogen synthase kinase has been
done on enzymes purified from skeletal muscle.However,
Schlender and Reimann (22) showed that among several rat
tissues, kidney was the most abundant source of CAMPindependent glycogen synthase kinase. Little is known about
the regulation of glycogen synthase in tissues such as the
kidney with low concentrations of glycogen. The demonstration that the kidney cortical glycogen synthase activity ratio
was low and the Ao.s for glucose-6-P was high suggested that
the synthase highly
is
phosphorylated (23). Given the predominance of CAMP-independent glycogen synthase kinase in
this tissue (24) and the absence of Ca2+-calmodulin-stimuGlycogen synthase is the rate-limiting enzyme in glycogen lated glycogen synthase kinase activity (23), it is highly likely
synthesis (1). The complex control of the enzyme involves that the CAMP- and Ca2+-calmodu~in-independent
glycogen
allosteric regulation as well as covalent modification via phos- synthase kinases are responsible for these properties of renal
phorylation-dephosphorylation which is under hormonal con- cortical glycogen synthase. We recently reported on the partrol (2-4). Picton et al. ( 5 ) have identified seven phosphoryl- tial purification of GSK-P’ from porcine renal cortex (23),

We recently reported the partial purification of a
CAMP-independent and Ca2+-calmodulin-independent
glycogen synthase kinase from porcine renal cortex
(Schlender, K. K., Beebe, S . J., and Reimann, E. M.
(1981) Cold Spring Harbor Conf. Cell Proliferation,
389-400). Subsequent purification indicated that the
enzyme preparation consisted of at least three forms
of glycogen synthase kinase which could be resolved
by ATP gradient elution from aminoethylphosphateagarose (AEP-agarose). The predominant form of glycogen synthase kinase, which eluted from AEP-agarose between 2 and 6 m M ATP, was purified approximately 800-fold and is designated GSK-A1. It had a
molecular weight of 45,000-50,000 as determined by
gel filtration andsucrose density gradient centrifugaof
tion. It catalyzed the transfer of l mol of 32P/m~l
synthase subunit into alow molecular weight (10,000)
CNBr peptide which was tentativelyidentified as Ser7 (site 2) by high performance liquid chromatography,
This phosphorylation decreased the activity ratio (activity in theabsence of glucose-6-P divided by activity
in the presence of 7 . 2 mM glucose-6-P) from 0.95 to
about 0.55. GSK-A1 appeared to be specific for and
had low so.s values for both substrates, ATP (13 SM)
and glycogen synthase (0.3-0.4 p ~ )The
.
enzyme could
not use GTP as the phosphate donor. GSK-A1 was not
affected by the protein kinase inhibitor,CAMP,cGMP,
Ca2+-calmodulin,EGTA, or trifluoperazine and had a
broad pH optimum (pH 7.0-8.5). A second form, GSKA2, was eluted from AEP-agarose between 7 and 9 mM
ATP. GSK-A2 could transfer a 2nd mol of “P/mol of
synthase subunit and decreased the activity ratio to
0.30. The interrelation among these multiple forms is
not clear, but the data suggest that multiple kinases
are required to form the highly inactivated glycogen
synthase in renaltissues.
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We now report that a recently developed agarose resin containing an aminoethylphosphategroup can be used to isolate
multiple formsof glycogen synthase kinasewhich are present
in porcine renal cortex.At leastthreeforms of glycogen
synthase kinase were separated by ATP gradient elution of
glycogen synthase kinase fromAEP-agarose. The major form
of glycogen synthase designated GSK-A1 was purified and
characterized.
EXPERIMENTALPROCEDURES
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Materials-Rabbit skeletal muscle glycogen synthase was prepared
through the polyethylene glycol precipitation step followed by phosphocellulose chromatography (glycogen-free)or through the ethanol
precipitation step (glycogen-bound)as previously described (25). The
inhibitor of the CAMP-dependent protein kinase (26) and catalytic
subunit of cyclic AMP-dependent protein kinase (27) were prepared
as previously described. Phosphorylase b was prepared from rabbit
skeletal muscle by the method of Fischer and Krebs (28). Phosphorylase kinase was prepared from rabbit skeletal muscle through the
Sepharose 4Bgel filtration step (29) or was a gift from Dr. Ted
Chrisman (Howard Hughes Medical Institute, Department of Physiology, Vanderbilt School of Medicine). [Y-~'P]ATPwas prepared
according to the method of Walseth and Johnson (30). Dr. Simon
Pilkis (Department of Physiology, Vanderbilt School of Medicine)
kindly provided the following: 6-phosphofructo-l-kinase,
6-phosphofructo-2-kinase, and fructose 2,6-bisphosphate. Dr. Jackie Corbin
(Howard Hughes Medical Institute, and Department of Physiology,
Vanderbilt School of Medicine) generously provided beef lung cGMPdependent protein kinase, rabbit skeletal muscle type I, and beef
heart type I1 regulatory subunit of cyclic AMP-dependent protein
kinase. Immersible Cx ultrafilters were purchased from the Millipore
Corp. AEP-agarose was a product from Pierce Chemical Co. All other
chemicals and reagents were obtained from sources previously indicated (25).
Swine kidneys were obtained from the local slaughterhouse. Approximately 15-30 min after the animals were killed, the kidneys
were placed on ice and transported to thelaboratory for dissection to
remove the cortex. In some experiments fresh cortex was used and in
others the tissue was stored a t -70 "C for up to 4 weeksbefore
isolation of glycogen synthase kinase. When the cortex was stored at
-70 "C for longer periods of time, the recovery of glycogen synthase
kinase in the first and/or second chromatography steps was significantly reduced.
Glycogen Synthase Kinase Assays-Unless otherwise indicated,
glycogen synthase kinase activity was determined by measuring the
inactivation of rabbit skeletalmuscle glycogen synthase aspreviously
described (25) with the following changes. The buffer was 35 mM
Tris-HC1 (pH 7.8 a t 25 "C), and thereaction mixture contained 1 mM
ATP, 2 mM Mg(Ac),, 0 or 4 mM NaCl, and 0 or 0.002% Brij 35. An
inactivation unit of glycogen synthase kinase activity is defined as
the amount of enzyme which causes the glycogen synthase activity
measured in the absence of glucose-6-P (31)to decrease by 1milliunit/
min at 30 "C.Phosphorylation by kinases did not change the activity
measured in the presence of glucose-6-P. Kinase activity was linear
with time and dilution over a very narrow range, but resonable
estimates of activity could be obtained when the activity ratio (activity in the absence of glucose-6-P divided by activity in the presence
of 7.2 mM glucose-6-P) was reduced from the initial value of 1.0 to
between 0.95 and 0.75.
Phosphorylation and inactivation of glycogen synthase was carried
out as previously described (25) with the following exceptions. The
reaction mixture included 50 mM Tris-HC1 (pH 7.8 at 25 -C), 1.9 or
9 mM P-glycerol phosphate, and 0 or 4 mg of glycogen/ml. At various
time points, aliquots were removed and analyzed for protein-bound
32Por activity ratio. One glycogen synthase kinase phosphorylation
unit is equal to 1 pmol of 32Pincorporated into glycogen synthase/
min.
Purification of Glycogen Synthase Kinase from Porcine Renal Cortex-A procedure was developedto purify the major glycogen synthase
kinase from porcine renal cortex. Frozen cortex (250 g) was thawed
for 15 min in cold running tap water and then homogenized in a
Waring blender with 625 ml of 8 mM K2HP04,2 mM KHzPOI, 1 mM
EDTA, 0.5 mM PMSF, and 250 mM sucrose (pH 7.8). All operations
were carried out at 0-4 "C unless otherwise stated. The homogenate
was centrifuged for 50 min a t 30,000 X g. The supernatantwas filtered
through glass wool. The clear extract was added to 190 ml of phos-

phocellulose which had been equilibrated in homogenizingbuffer.
After 1 h the suspension was filtered on a funnel equipped with a
porous polyethylene plate, washed with 1liter of homogenizing buffer,
and thenwashed with 1 liter of homogenizing buffer (containing 150
mM NaC1) without sucrose. The resin was then suspended in the
latter buffer, poured into a 5-cm diameter column, and washed with
an additional bed volume of buffer containing 150 mM NaC1. The
GSK-P was eluted with buffer containing 8 mM K2HP04, 2 mM
KH2P04, 1 mM EDTA, 0.5 mM PMSF, and 500 mM NaCl (pH 7.3).
In a series of nine batch adsorptions carried out in this manner,
recoveries of GSK-P in the 500 mM NaCl eluates were 42.2 ? 3.3%
(mean f S.E.) and the fold purification was 16.5 f 3 (mean ? S.E.).
No additional activity was detected by the glycogen synthase kinase
assay when the column was washedwith 1M NaCl, but activity could
be detected by measuring 32Pincorporation into glycogen synthase.
The phosphocellulose eluate (GSK-P) was diluted 3-fold with 5
mM K2HP04,5 mM KH2P04,1 mM EDTA, 0.5 mM PMSF (pH 6.9),
and applied to a hydroxyapatite column (2.6 X 11.3 cm) equilibrated
in the above buffer containing 150 mM NaC1. After the sample was
applied, the column was washed with the following sequence of
buffers: 1) 3 bed volumes of 6 mM KzHP04,4 mM KHzP04, 1 mM
EDTA, 0.5 mM PMSF (Buffer A, pH 7.1) containing in addition 500
mM NaCl; 2) 2 bed volumes of Buffer A and 3) 3 bed volumes of
Buffer A containing 15 mM potassium citrate. These washes eluted
little or no glycogen synthase kinase activity. Glycogen synthase
kinase was then eluted with Buffer A containing 15 mM potassium
citrate and350 mM NaC1.
The hydroxyapatite eluate (15.5 ml) was then adjusted to pH 7.8
a t 1 "C with 45 ml of 10 mM K2HP04,1 mM EDTA, and 0.01% Brij
35. The preparation was then adjusted to a final volume of 230 ml
with 8 mM KzHPO,, 2 mM KHzP04, 1 mM EDTA, 0.01% Brij 35 (pH
7.8). This diluted the NaCl in the hydroxyapatite eluate to about 20
mM. The inclusion of the detergent Brij 35 aided in the stability of
glycogen synthase kinase under these conditions of high dilution.
Dialysis to remove salt often resulted in greater losses of activity
than when the preparation was diluted in the presence of Brij 35.
The entire volume was applied to an AEP-agarose column (0.9 X 12
cm) equilibrated in 8 mM K2HPO4,2 mM KH2PO4, and 0.01% Brij 35
(pH 7.8). After the sample had been applied, the column was washed
with 2 bed volumes of equilibrating buffer. The column was eluted
with a linear gradient of0-15
mM ATP in equilibrating buffer
adjusted to pH 7.8 (total volume 60 ml). The AEP-agarose column
resolved glycogen synthase kinase activity into two components designated GSK-A1, eluting between 2 and 6 mM ATP, and GSK-A2,
eluting between 7 and 9mM ATP (Fig. lA).Fractions were pooled as
indicated in Fig. lA and concentrated using an immersible Millipore
filter. No additional activity could be eluted by washing the column
with buffer containing 500 mM NaCl.
In addition to the forms of glycogen synthase kinase that were
bound (Fig. lA), about 10% of the glycogen synthase kinase activity
was not bound to thecolumn under these conditions. When the flowthrough fractions from the first AEP-agarose column were rechromatographed ona second AEP-agarose column, all the glycogen
synthase kinase was bound to thecolumn (Fig. 1B).When the column
was eluted with an ATP gradient, at least three peaks were resolved.
Two small peaks of activity eluted below 2 mM ATP, and a third
major peak of activity eluted between 2 and 6 mM ATP. The latter
presumably represents GSK-A1 which was overloaded
on the primary
column.
The pooled and concentrated GSK-A1 and GSK-A2 were separately chromatographed on a Sephadex G-150 fine column (1.5 X 86
cm) (Fig. 2). Both of the glycogen synthase kinase preparations eluted
as single peaks with apparent molecular weights of about 45,000. A
protein peak preceded the glycogen synthase kinase activity of GSKA1 (Fig. 2 A ) . When individual fractions were separately subjected to
SDS-PAGE, the protein peak which preceded the glycogen synthase
kinase activity appeared as a band near 30,000 daltons (not shown).
To minimize contaminatingprotein, only fractions 48-54 were pooled.
The poolwas concentrated 6-fold using the immersible Millipore
filter. On SDS-PAGE this preparation still contained the 30,000dalton protein in addition to a prominent band at 45,000 and three
minor bands between 30,000 and 45,000. Fractions 42-51 from the
second Sephadex G-150 column were pooled for GSK-A2 (Fig. 2B).
The pooled fractions were concentrated 8.5-fold with the immersible
Millipore filter. A summary of the purification is presented in Table
I.
Gel Filtration-Sephadex G-100 or G-150 columns were calibrated
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FIG. 1. Aminoethylphosphate-agarosechromatography. A,
chromatography was carried out asdescribed in the text. The proteins
were eluted with a linear ATP gradient. At an elution volume of 330
ml, the column was washed with 8 mM K2HP04, 1mM EDTA, 0.01%
Brij 35, 500 mM NaCl. B, rechromatography of AEP-agarose flowthrough fractions. The flow-through fractions were pooled and rechromatographed on the same AEP-agarose column (1.6 x 2.5 cm).
The proteins were eluted with a 60-ml linear gradient between 0 and
12 mM ATP. Fractions (0.85 ml) were assayed for glycogen synthase
kinase activity (e),ATP (a),and protein (A).
using standard proteins. The proteins, their molecular weights, and
their Stokes radii in nanometers were: blue dextran (void volume
marker); bovine serum albumin (67,000,3.6); ovalbumin (45,000,2.7);
catalytic subunit of CAMP-dependent protein kinase (40,000, 2.7);
carbonic anhydrase (30,000, 2.3); chymotrypsinogen A (25,000, 2.41,
and adenosine (inclusion volume marker).
Sucrose Density Gradient Centrifugation-Sucrose gradients were
done by modification of the method described by Brandt et al. (32).
Glycogen synthase kinase was applied to the top of a 5-25% sucrose
gradient in 6 mM K,HPO,, 4 mM KH2P04, and 1 mM EDTA (pH
7.1). Catalase (10 mg/ml, s20,w = 11.1) was included as an internal
standard, and catalase and lactoperoxidase (10 mg/ml, ~ 2 0 =
, ~ 5.4)
were applied to a separate gradient as external standards. Centrifugation was for 16 h a t 40,000 rpm in an SW 50.1 rotor in a Beckman
L2-65B ultracentrifuge at 4 "C. The molecular weight and frictional
ratio were calculated as described by Siege1 and Monty (33).
Polyacrylamide Gel Electrophoresis-Ten or 7.5% slab SDS-PAGE
was carried out as described by Laemmli (34). Gels were stained with
0.12% Coomassie brilliant blue A-250 in 7.5% acetic acid and 50%
(v/v) methanol.
High Performance Liquid Chromatography-Reverse phase high
performance liquid chromatography of tryptic peptides derived from
phosphorylated glycogen synthase was done in collaboration with Dr.
Thomas R. Soderling (Howard Hughes Medical Institute, Department of Physiology, Vanderbilt School of Medicine). This procedure
will separate phosphorylation sites la, lb,2, 3abc, and 5 (35).
Other Methods-Proteins were determined by the Lowry method
as modified by Hartree (36), by absorbance at 280 nm, or by the
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FIG. 2. Sephadex G-150 gel filtration of GSK-A1 and GSKA2. A, concentrated GSK-A1 from an AEP-agarose column was
applied to a Sephadex G-150 column equilibrated in 6 mM K2HP04,
4 mM KH~POI,1 mM EDTA, 200 mM NaCl, and 0.01% Brij 35.
Fractions between 48 and 54 were pooled and concentrated by Millipore filtration. B, concentrated GSK-A2 from an AEP-agarose column was applied to a Sephadex G-150 column as described above.
Fractions between 42 and 51 were pooled and concentrated by Millipore filtration. Fractions were assayed for glycogen synthase kinase
activity (e)and protein (A).The arrows indicate the elution volume
of ovalbumin.

TABLEI
Purification of porcine renal cortical glycogen synthase k i m e
Details of the purification procedure were as described in the text.
Assay of glycogen synthase kinase was by inactivation of glycogenbound synthase. Proteins were determined by the method of Hartree
(36). AEP-agarose 1 and AEP-agarose 2 represent AEP-agarose
uooled volumes 272-292 and 300-311, respectively, as indicated in
Pig. IA.
__
'urifi:ation
__
%
-fold
mg
Extract
100 25.81
12,615 325,860
Phosphocellulose
395
321
39
12.4
126,620
Hydroxyapatite
28.9
16
68.5
1,768 51,130
AEP-agarose 1 (concen11.5
30.2
780 2.8
8,970
trated)
Sephadex G-150 1 (con0.16 3,213 19,631
1.0 761
centrated) (GSK-A1)
AEP-agarose 2 (con2.8
0.3 13.8
1,000 355
centrated)
Sephadex G-150 2 (con772 4,787
0.16
0.2 186
centrated) (GSK-A2)
I
I
I
__

method of Bradford (37). Kinetic parameters were calculated by
nonlinear regression analysis (38).
RESULTS

Multiple Forms of Glycogen Synthase Kinase from Porcine
Renal Cortex-Gel filtration of crude extracts, prepared as
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TABLEI1
described above, on Sephadex G-100 revealed several molecProperties of GSK-A1
ular weight forms of glycogen synthase kinase with activity
Gel filtration and sucrose density gradient centrifugation were
insensitive to CAMP, Ca*’-calmodulin, orthe heat-stable
carried out as described under “Experimental Procedure” and in the
inhibitor of CAMP-dependent proteinkinase
(datanot
text. pH studies are described in the text.
shown). Compiling data from several experimentsdemonProperty
strated a major glycogen synthase kinase activity peak eluting
with an apparent molecular weight of 45,000-50,000. In adStokes radius (nm)
2.85
SZ0,W
4.00
dition there was a prominent shoulder of activity eluting at
Molecular weight
50,000-55,000. A small peak of activity elutedat >70,000, and
Gel filtration
45,000
in some experiments activity elutedwith an apparent molec48,000
Calculated
ular weight of 35,000. The appearance of multiple peaks of
Frictional ratio
1.20
glycogen synthase kinase activity on Sephadex G-100was optimum
pH
7.0-8.5
unaffected by the presence of protease inhibitors (PMSF,
benzamidine, and EDTA).Similar gel filtration profiles were
TABLE
111
obtained under a variety of conditions including the use of
of GSK-A1
Protein
substrate
specificity
fresh or frozen tissue, homogenization with or without sucrose
The reaction wascarried out as describedunder “Experimental
present, or when 50 mM Tris, 200 mM NaCl (pH 7.5), or 10
Procedures” for the phosphorylation of glycogen synthase except the
mM potassium phosphate, 200 mM Naci (pH7.2), or 100 mM substrate was varied. Each substrate was at 0.1 mg/ml. Tris-HC1 was
phosphate (pH 7.2) buffer systems wereused. When gel 50 mM and @-glycerolphosphate was 9 mM. The 32P-proteinwas
filtration column fractions were assayed for inhibitor-sensi- isolated on Whatman ET-31 cellulose filter papers as previously
tive histone kinase activity, nearly all of the activity was described (25). Time courses wererunin duplicate, and the rates
CAMP-dependent and appeared inthe void volume, indicating were determined by regression analysis. The data are expressed as
the mean f S.E.
that the CAMP-dependent protein kinase chromatographed
Glycogen synthase kinase
as the holoenzyme with little, if any, free catalytic subunit
Substrate
A1 activity
present.
pmol/min/pg
Previous studies had shown that glycogen synthase kinase
Synthase (glycogen-bound)
76 f 2.6
of rabbit kidney extracts could be separated into two types
79 5.7
Synthase (glycogen-free)
(GSK-D and GSK-P) by chromatography on phosphocellu0.1 f 0.5
Phosphorylase b
lose and DEAE-cellulose (24). As measured by the synthase
Phosphorylase b kinase
3.6 +- 3.5
inactivation assay, about 25%of the glycogen synthase kinase
0.8 f 0.6
Histone (mixed)
4.9 rt- 1.3
Phosvitin
activity in swine renal cortex was GSK-D and 75%was GSK0.0 f 2.1
Casein
P. GSK-D and GSK-P eluted from Sephadex G-100 with
apparent molecular weights of 50,000-55,000 and 45,00050,000, respectively. Using the synthase phosphorylation as- enzyme chromatographed on a Sephadex G-100 column in the
say, a small amount of a third type of glycogen synthase absence of the detergent Brij 35 (23). When the value of 2.85
kinase could be detected. The latter, which was eluted from nm for Stokes radiusand thesedimentation coefficient of 4.0
phosphocellulose by about 1M NaCl, also contained heparin- were used, the calculated molecular weight was 48,000 for
sensitive casein kinase activity and is likely similar to the GSK-A1 (Table11). This value is in good agreement with the
enzyme purified from rabbit skeletal muscle designated PCQ.7 apparent molecular weights of 45,000 for GSK-A1 determined
(18,19), casein kinase 2 (20), or GSK-5 (21).
from the calibrated Sephadex G-150 chromatography (Table
Purification of GlycogenSynthase Kinases-The major form 11) and theprominent band obtained on SDS-PAGE(45,000).
of glycogensynthase kinase, designated GSK-A1, was purified
Effect of pH on Activity of GSK-AI-The effect of pH on
from porcine renal cortex as described under “Experimental GSK-A1 activity was determined with MES buffer between
Procedures.” GSK-A1 was purified approximately 1000-fold pH 5.5 and 7.0 and Tris buffer between 7.0 and 8.5. The
with recoveries of 1-3% of the glycogen synthase kinase enzyme had a broad pH optimum with essentially the same
activity of the initial extract. A second glycogen synthase activity between pH 7.0 and 8.5. There was a marked decrease
kinase, designated GSK-A2, was purified to a lesser extent in activity as thepH was decreased from pH 7.0 to 5.5.
(Table I). These enzymes were used for the studies described
Nucleotide Substrate Specificity of GSK-At-Since some of
below.
the glycogen synthase kinases purified from other laboratories
Sedimentation Coefficient, Stokes Radius, and Molecular have been reported to use GTP (19-21) and dATP (25) as
Weight of GSK-Al-Sucrose density gradients were carried phosphoryl donors, it was ofinterest to determine the nucleoout on glycogen synthase kinase after purification through tide specificity of GSK-A1. GSK-A1inactivated glycogen
the Millipore filter concentration of the hydroxyapatite eluate synthase most effectively when 1mM ATP was the phosphate
as described under “Experimental Procedures.” The sedimen- donor. dATP was only about 15% as effective as ATP. GSKtation coefficient was calculated to be 4.0. The peak widths A1 could not use 1 mM GTP, CTP, ITP,or UTP in place of
of the standards and glycogen synthase kinase activity were ATP.
essentially the same. Since the hydroxyapatite eluate conProtein Substrate Specificity of GSK-At-Table 111 shows
tained both GSK-A1and GSK-AB, these results indicatethat the protein substrate specificity of GSK-AI. Both glycogenthese two forms have similar sedimentation coefficients.
free and glycogen-bound glycogen synthase served equally
The Stokes radius of GSK-A1 was determined on a cali- well as substrates. GSK-A1 was unable to catalyze the phosbrated Sephadex G-150 column in thepresence of 0.01% Brij phorylation of phosphorylase kinase when the substratecon35. The detergent was included to stabilize the enzyme and centration was 0.1 (Table 111) or 0.4 mg/ml (data not shown)
was also present during the calibration of the column with or phosphorylase when the concentration was 0.1 (Table Iv)
protein standards. The Stokes radius was determined to be or 19 mg/ml (data notshown). Histone,casein, and phosvitin
2.85 nm (Table 11). This value was not significantly different have often been used to follow the purification of glycogen
from the value of 2.95 nm obtained for the partially purified synthase kinase. Theseproteins were poor substrates for
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to give net phosphorylation in the presence of kinase.
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FIG. 4. Time courses for the phosphorylation (upper) and
inactivation (lower)of glycogen-boundglycogen synthase by
40
GSK-P. GSK-P was added to yield a final concentration of 0 (0),
(a),
210 (O), and 1050 (A)phosphorylation units/ml. In thepresence
of GSK-P, net phosphorylation is presented.

cogen synthase can be phosphorylated at multiple sites. Several approaches to the
localization of the phosphorylation
sitesonthesynthase
molecule were attempted.Thefirst
approach used trypsin to partially digest the 32P-labeled synthase. After limited trypsin digestion, two classes of peptides
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GSK-A1 (Table 111). GSK-A1 was unable to phosphorylate
cGMP-dependent protein kinase, type I1 regulatory subunit,
type I regulatory subunit of CAMP-dependent protein kinase
(data not shown). In addition, GSK-A1
was unable t o incorporate phosphate into 6-phosphofructo-1-kinaseor 6-phosphofructo-2-kinase (data notshown). Therefore, GSK-M appears to be highly specific for glycogen synthase.
Potential Modifiers of GSK-A1 Activity-Several potential
modifiers of GSK-A1 activitywere tested. NaClwas found to
be inhibitory and itwas, therefore, important to remove salt
before assaying glycogen synthase kinase fractions. 64 mM
NaCl caused approximately 50%inhibition of GSK-A1. Other
inhibitors of GSK-A1 activity included 1 mM Na2S04 (55%),
0.5 mM UDP (30%), 0.5 mM UDP-glucose (35%), 0.5 mM
ADP (62%), and 50 mM KF, the most effective inhibitor
(95%).The sugar phosphates glucose-6-P,glucosamine 6phosphate, and glucose-1-P (0.5 mM each) had no effect on
GSK-A1 activity. Glycogen synthase kinase activity was not
affected by 1 mM fructose 2,6-bisphosphate, 2 mM EGTA, 0.2
mM Ca2+and 0.4 FM calmodulin, 5 p M CAMP, 5 Fm cGMP,
80 p~ trifluoperazine, or 5 pg of phosphatidylserine/ml in the
presence of 0.2 mM Ca2+ and0.4 WM calmodulin.
Kinetic Parameters of GSK-AI-The s0.5 values for glycogen
synthase and ATP
were determined for GSK-A1. The kinetics
for glycogen synthase were determined using the following as
substrates: 1) glycogen-bound synthase; 2) glycogen-free synthase with 4 mg of glycogen/ml present; and 3) glycogen-free
synthase. Assuming a tetrameric structure for glycogen synthase, the K,,, values for GSK-A1 were 0.26, 0.46, and 0.33
PM,respectively. The Hill coefficients were not differentfrom
1.0. The presence of glycogen had very little effect on the
V,,,. The K,,, value using ATP as the variable substrate was
determined tobe 13.1 FM.
Phosphorylation and Inactivation of Glycogen Synthase by
GSK-A1 and GSK-P-Phosphorylation and inactivation of
glycogen synthase by several concentrations of GSK-A1 and
GSK-P are shown in Figs. 3 and 4, respectively. Little if any
change in the activity ratio was seen in the control experiment. When 70 phosphorylation units of GSK-Al/ml were
present, phosphate incorporation reached a maximum of 0.5
mol of 32P/molof synthase subunit and did not change over
the next 90 min of incubation (Fig. 3, upper). The activity
ratio was reduced to about 0.75 (Fig. 3, lower). When the
concentration of GSK-AI (in unitslml) was 835, 1670 (Fig.
3), or 3000 (not shown), most of the reaction was completed
within 3 min and after 2 h of incubation no more than 1 mol
of "P/mol of synthasesubunit was incorporated and the
activity ratio was reduced to about 0.5.
Fig. 4 shows the same type of experiment with GSK-P.
Forty phosphorylation units of GSK-P/ml catalyzed the incorporation of nearly 1 mol of 32P/mol of synthase subunit in
60 min. When 1050 units of GSK-P/ml were incubated with
synthase, nearly 2.5 mol of 32P/mol of synthase subunit were
incorporated and the activity ratio was reduced to less than
0.20. A similar concentration of GSK-A1 (835 units/ml) catalyzed incorporation of only 1 mol of 32P/mol of synthase
subunit and reduced the activity ratio to 0.50-0.60 (Fig. 3).
The correlation of phosphorylation with activityratio for
GSK-A1 and GSK-P is illustrated in Fig. 5. GSK-A2 (600
units/ml) catalyzed phosphorylation of synthase to the level
of1.7 mol of 32P/mol of synthase subunit and reduced the
activity ratio to 0.3 (data not shown). Thus, it appears that
kinases in GSK-Presolved by AEP-agarose chromatography
have different specificities with respect to the phosphorylation sites on glycogen synthase.
Glycogen Synthase Phosphorylation Site Specificity-Gly-
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FIG. 6. SDS-PAGE of CNBr-cleaved s2P-labeled glycogen
synthase. The glycogen synthase was phosphorylated to a level of
0.8 ml of 32P/mol of synthase subunit. After CNBr cleavage, as
described by Soderling et al. (40), the sample was subjected to SDS-

0.4

of CAMP-dependent protein kinase was found to be in the
trypsin-sensitive domain (Table IV).
A second approach was to use CNBr to cleave the 32P0
labeled synthase molecule (40). Synthase was phosphorylated
0
0.5
1
1.5
2
2.5
to thelevel of 0.80 mol of 32P/molof a subunit with GSK-A1.
Mol 32P/85,000 g
After
cleavage with CNBr, thesynthase was then electrophoFIG. 5. Correlation of glycogen synthase phosphorylation
and inactivation catalyzed by GSK-A1 (A) and GSK-P ( B ) . resed on SDS-PAGE. The gels were then exposed to film and
The activity ratio was plotted as a function of the phosphorylation the resulting autoradiogram was scanned on a densitometer
state using data obtained from experiments as described in Figs. 3 (Fig. 6). The scan indicated that the major phosphorylated
and 4.
site was on a low molecular weight peptide (approximately
10,000). Cohen et al. (21) have recently shown that when 32P.TABLE
IV
labeled glycogen synthase is digested by low concentrations
Distribution of phosphate between trypsin-sensitive and trypsinof trypsin, sites 2,3a, 3b, and 3c are inthe trypsin-insensitive
insensitive regions of glycogen synthase
domain. In addition, Cohen et al. indicated that the low
32P-IabeIedgiycogen synthase (glycogen-bound) wasprepared to molecular weight CNBr peptide contained only site 2 (Le.
various degrees of
phosphorylation with GSK-A1, GSK-P, orcatalytic
subunit of CAMP-dependent protein kinase. The determination of Ser-7). Consequently, since the GSK-A1 synthase phosphotrypsin-sensitive and trypsin-insensitive regions of 32P-labeledgly- rylation site is trypsin-insensitive and on a low molecular
cogen synthase was determined as previously described(40). The data weight CNBr peptide, it appears that GSK-A1 phosphorylates
(phosphates/subunit) are expressed as the mean f S.E. (n = 4).
site 2. This was confirmed by the use of reverse phase high
performance liquid chromatography of tryptic digests. When
Kinase
GSK-A1 incorporated 0.80 mol of 32P/mol of synthase subunit, 95% of the label eluted in a position corresponding to
site 2 (Fig. 7). The small peak eluting near 115 min and
0.22 f 0.01 0.01 f 0.01 0.21 f 0.01
95
GSK-AI
preceding the major peak appears to be a breakdown product
0.38 f 0.01 -0.04 f 0.03 0.42 f 0.02
111
of site 2.2
0.74 f 0.00
f 0.05 0.03 f 0.05 0.77
96
To further establish that Ser-7 was the site phosphorylated
by GSK-A1, glycogen synthase was phosphorylated by GSK0.33 f 0.01 -0.01 f 0.06 0.34 f 0.04
103
GSK-P
A1 to the extent of 0.7 mol of 32P/mol of subunit. The 32P1.26 f 0.07
f 0.03 1.41 k 0.03 -0.15112
90
1.88 f 0.01 0.18 f 0.05 1.70 0.06
synthase was then incubated under standard phosphorylation
conditions with phosphorylase kinase, an enzyme specific for
15
CAMP-dependent 0.68 -C 0.05 0.58 -t 0.08 0.1 f 0.03
Ser-7 (21). Aliquots were removed at 15, 30, and 45 min and
protein kinase
32Pbound to synthase was determined. There was no additional phosphorylation of synthase by the added phosphorylare generated. These can be differentiated by their solubility ase kinase (data not shown). When glycogen synthase was
in trichloroacetic acid (39) (Table IV). When synthase was incubated in an identical manner except GSK-A1 was not
phosphorylated to a level of 0.7 mol of 32P/mol of synthase added, subsequent addition of phosphorylase kinase resulted
subunit by GSK-AI, essentially all of the phosphate was in theincorporation of 0.4 mol of 32P/molof synthase subunit
incorporated in the trypsin-insensitive site (trichloroacetic within 15min. Phosphorylation of glycogen synthase byphosacid-insoluble). Likewise, when GSK-P catalyzed the transfer phorylase kinase leveled off at about 0.5 mol of 32P/mol of
of 0.3, 1.3, or 1.9 mol of 32P/mol of synthase subunit, by and subunit. Conversely, if glycogen synthase was first phospholarge all of the 32Pwas associated with trypsin-insensitive
rylated by phosphorylase kinase and then incubated with
sites. Since GSK-P contains a mixtureof kinases, it appeared GSK-A1, little additional phosphate was incorporated into
that all of these forms had a high specificity for the trypsin- synthase.
insensitive phosphorylation domains. In contrast, the first
* T. R. Soderling, personal communication.
phosphate incorporatedinto synthaseby the catalytic subunit
0.2

*
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PAGE as described under"ExperimentalProcedures."The gels were
exposed to film and the resulting autoradiogram was scanned on a
densitometer. The protein standards and molecular weights include:
a, chymotrypsinogen (25,700); b, lysozyme (13,300); c, bovine trypsin
inhibitor (6,000);d, insulin (3,000),and e, the dye front.
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strate that porcine renal cortex contains multiple forms of
glycogen
cyclic nucleotide- and Ca2+-calmodulin-independent
synthase kinases. The major glycogen synthase kinase forms
in crude extracts were bound to phosphocellulose and eluted
80 at low ionic strength (GSK-P),while a lesser form, GSK-D,
failed to bind to thephosphocellulose. Since GSK-D appeared
to be slightly larger thanGSK-P
(50,000-55,000 Versus
70 45,000-50,000), it is possible that the loss of a small peptide
may differentiate these two forms. Although protease inhibitors had no effect on the appearance of multiple forms of
60glycogen synthase kinase, it is possible that these were generated by resistant proteases or by a nonproteolytic mechaX
I 50nism. Since renal cortex contains a heterogeneous population
n
0
of cells, it is also possible that these forms originate from
n
different cell types. These activities were determined using
1 40the conversion assay which was used to detect only kinases
which inactivate glycogen synthase and have low K,,, values
for this substrate. Consequently, the phosphorylation assay
30 was required to detect the heparin-sensitive phosvitin/casein
kinase which phosphorylates but does not inactivateglycogen
synthase (18-21).
We have previously reported on the partial purification of
GSK-P from porcine renal cortex (23). Although those data
10
suggested a homogeneous preparation with respect to kinase,
n
subsequent purification demonstrated GSK-P to be a heter0
ogeneous
group of glycogen synthase kinases. These kinases
,
were unresolvable by procedures previously utilized including
0
20
40
60
80
100
120
ld
successive salt step elutions or gradient elution from phosTIME (minutes)
phocellulose, gradient elution from CM-cellulose, DEAE-celFIG. 7. Reverse phase high performance liquid chromatog- lulose, or gel filtration. Only ATP gradient elution from AEPraphy of 3aP-labeled glycogen synthase tryptic peptides. The agarose was capable of separating multiple forms of renal
procedure was carried out according to themethod of Juhl et al. (35).
Glycogen synthase was phosphorylated to a level of 0.7 mol of 32P/ GSK-P. Much higher concentrations of sodium chloride or
molof synthase subunit with GSK-A1 and then precipitated with phosphate were required to elute glycogen synthase kinase
10%trichloroacetic acid. The precipitate was washed twice with ether activity from AEP-agarose and there was no separation of
and taken up in 100 mM ammonium bicarbonate (pH 8.0) and then forms.3 When crude extracts were directly chromatographed
digested with 1 mg/ml of trypsin for 5 h. The digest was then on AEP-agarose, about 70% of the glycogen synthase kinase
chromatographed on a Beckman 421 high performance liquid chro- activity eluted at thesame position as GSK-A1.3This suggests
matograph using an acetonitrile gradient in 0.1% trifluoroacetic acid
on a Beckman c-18 Ultrasphere ODS column (0.46 X 25 cm). The that GSK-A1 was not generated by the purification procedure.
gradient flow rate was 1 ml/min as follows: 0.5% acetonitrile for 10 It is interesting that GSK-A1 and the otherkinases comprismin, 5-38% for 100 min, and 38-50% for 5 rnin. Two-ml fractions ing GSK-P readily bound to resins containingphosphate
were collected. 32Pwas determined by Cerenkov's counting. The groups. GSK-P bound tightly to phosphocellulose but poorly
arrows indicate the elution positions: a, site la; b, site 5; c, sites 3abc; to CM-cellulose. Since both sodium chloride and sodium
d, site lb; e, site 2.
citrate were required for elution, the behavior of these kinases
on hydroxyapatite suggests that they bound to the calcium
site as well as to thephosphate site.
DISCUSSION
The most remarkable feature of GSK-A1 is its specificity
Multiple forms of CAMP- and Ca"-calmodulin-independfor
glycogen synthase and ATP. In addition, GSK-A1 cataent glycogen synthase kinases have been previously demonstrated inrabbitskeletal
muscle (18, 21, 41), rat skeletal lyzed phosphorylation of only one site at or near Ser-7 at the
muscle (25), and several other rat tissues (22). Schlender and NH, terminus of the molecule. Several separate pieces of
3 2 P / m ~of
l
Reimann (22, 24) subdivided glycogen synthase kinases into evidence confirm this finding. Only 1 molof
subunit
was
incorporated
into
glycogen
synthase.
This
phosforms that bind to phosphocellulose (GSK-P) andforms that
bind to DEAE-cellulose (GSK-D). Schlender et al. (25) used phate was located in a M, = 10,000-12,000 CNBr peptide of
Sephadex G-100 to separate two forms of GSK-P from rabbit glycogen synthase andin atrypsin-insensitive peptide of
skeletal muscle. DePaoli-Roach et al. (18)further subdivided glycogen synthase. Glycogen synthase phosphorylated with
synthase kinases into forms that elute from phosphocellulose GSK-A1 could not be further phosphorylated by phosphoryla t low ionic strength (PC,, andPCo,) and forms that elute a t ase kinase. These observations are consistent with GSK-A1
high ionic strength (PC,,). Cohen et al. (21), using a procedure catalyzing the phosphorylation of glycogen synthase at Ser-7
similar to that of DePaoli-Roach et al. (18), have recently (site 2) (21). High performance liquid chromatography, done
separated three distinctglycogen synthase kinases designated in collaboration with Dr. Thomas R. Soderling, was a final
GSK-3, GSK-4, and GSK-5. The latter kinase appears to be piece of evidence demonstrating that GSK-A1 only catalyzed
the phosvitin/casein kinase designated PCo.7 by DePaoli- the phosphorylation of a site tentatively identified as Ser-7
Roach et al. (18, 19) or casein kinase 2 by Huang et al. (20). (site 2). Although the only known phosphorylation site near
This kinase differs from the other glycogen synthase kinases the NH, terminus of glycogen synthase is Ser-7, we have not
ruled out at thistime that phosphorylation occurs at another
studiedin that it phosphorylates but does notinactivate
glycogen synthase.
S. J. Beebe, E. M. Reimann, and K. K. Schlender, unpublished
Several lines of evidence are presented here which demon- results.
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It appears that more than one kinase participates in the
inactivation of renal cortical glycogen synthase. GSK-A1 catalyzed the transfer of only 1 mol of 32P/mol of synthase
subunit and reduced the activity ratio to about 0.5. GSK-A2
catalyzed the transfer of a 2nd mol of 32P/mol of synthase
subunit, but reduced the activity ratio to only 0.30. When
both GSK-A1 and GSK-A2 were combined, synthase was
phosphorylated and inactivated to the same degree as with
GSK-A2 alone. However, the GSK-P preparation catalyzed
the phosphorylation of at least three sites and reduced the
activity ratio to 50.10. This suggests that still another kinase,
a kinase activator, or substrate modulator is present in the
GSK-P preparation.
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site near Ser-7 onglycogen synthase. This substratespecificity for synthase but not phosphorylase or phosphorylase kinase suggests that GSK-A1 is also specific in its role in
glycogenesis. In similar studies GSK-A2 was found to evenly
distribute about 2 mol of 32P/m01of synthase monomer into
~ should be noted that these studies
sites la, 2, and 3a, b, c . It
used rabbit muscle glycogen synthase as substrate. It is not
known if the phosphorylation of renal glycogen synthase
would be.identical.
glyPhosphorylase kinase(Zl), Ca2+-calmodulin-dependent
cogen synthase kinase (15-17), and GSK-4 (21) are other
kinases which have been shown to catalyze the phosphorylation of Ser-7 on glycogen synthase. Since GSK-A1 did not
phosphorylate phosphorylase and was not stimulated by Ca2+calmodulin or inhibited by EGTA or trifluoperazine, this
kinase cannot be identified as phosphorylase kinase or the
Caz+-calmodulin-dependent glycogen synthase kinase. GSKA1 and GSK-4 (21) were similar inthat both were eluted from
phosphocellulose at low ionic strength andhave low Michaelis
constants and are specific for glycogen synthase and ATP.
However, GSK-4 bound to DEAE-cellulose and was eluted
with 0.2 M NaCI,while repeated attempts to use DEAEcellulose to purify GSK-A1 indicatedit would not bind under
the most favorable conditions. In addition, GSK-A1 was inhibited 50% by 64 mM NaCl while GSK-4 was stimulated by
a similarNaCl concentration (21). Based on gel filtration, the
apparent molecular weight was45,000-50,000 for GSK-A1
and 115,000 for GSK-4. Finally, GSK-A1 and the other kinases in GSK-P were not stable for extended periods of time
in the Trisbuffers used to purify GSK-4. Thus, it is clear that
major differences exist between GSK-A1 and GSK-4.
The glycogen synthase activity ratio in rabbit
kidney cortex
is low (0.05 and the A0.5 for glucose-6-P is high (2 mM) (23).
These two phenomena can be explained by extensive phosphorylation of cortical glycogen synthase in uiuo. Schlender
and Reimann (22) demonstrated that 80-95% of the glycogen
synthase kinase activity in rat kidney was independent of
CAMP.Also, 70-80% of the glycogen synthase kinase activity
of rabbit renal cortex or medulla was insensitive to the heatstable inhibitorof CAMP-dependentprotein kinase (23). Mendicino et al. (42) determined that the apparent K,,, of the
CAMP-dependent protein kinase for glycogen synthase (50
p ~ was
) about 1300 times the kidney glycogen synthase
concentration. These datasuggest that theCAMP-dependent
protein kinase plays modest
a
role in the inactivation of renal
synthase. Since no Ca2+-calmodulin-stimulated
glycogen synthase kinase activity could be detectedin renal cortex extracts
(23), it also appears that Ca2+-calmodulin synthase kinase
does not play animportant role in producing the highly
inactivated and phosphorylated glycogen synthase in kidney
cortex. Given the predominance of CAMP-independent glycogen synthase kinase in rabbitrenal cortex (23, 24) and
GSK-A1 in swine renal cortex, it is highly likely that this
class of kinases plays an important role in the regulation of
glycogen synthase in renal cortex. Although the regulatory
mechanism of these kinases has not yet been determined, it
is possible that control is afforded by known synthase effectors (UDP, UDP-glucose, ADP, andNa2S04) (43) which
caused some inhibition of GSK-A1 or by some as yet undefined regulators. This regulation could occur by an allosteric
modulation at thelevel of the substrateand/or kinase.

Purification and characterization of a cAMP- and Ca2+-calmodulin-independent
glycogen synthase kinase from porcine renal cortex.
S J Beebe, E M Reimann and K K Schlender
J. Biol. Chem. 1984, 259:1415-1422.
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